Akebia Therapeutics Inc. buy HC Wainwright
Start price
28.03.24
/
50%
€1.82
Target price
28.03.25
€5.55
Performance (%)
-28.89%
Price
07.05.24
€1.30
Summary
This prediction is currently active. The prediction for Akebia Therapeutics Inc. disappoints with a performance of -28.89%. This prediction currently runs until 28.03.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | 10.289% | 10.289% |
iShares Core DAX® | 2.831% | 1.236% |
iShares Nasdaq 100 | 2.918% | 0.640% |
iShares Nikkei 225® | 2.007% | -2.135% |
iShares S&P 500 | 2.257% | 0.451% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its price target raised by analysts at HC Wainwright from $5.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
17.11.23
17.11.23
€4.60
17.11.24
17.11.24
44.17%
07.05.24
07.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.11
27.09.23
27.09.23
€3.55
27.09.24
27.09.24
16.64%
07.05.24
07.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
28.08.23
28.08.23
€3.47
28.08.24
28.08.24
2.13%
07.05.24
07.05.24